Abstract
The crystal structures of the compounds 1-phenyl-2-(1H-1,2,4-triazolo-yl)-3-phenyl-propen-1-one (2), and 2,4-diphenyl-3-(1,2,4-triazolo-yl)-1H,4H-1,5-benzothiazepine (3) were obtained by single crystal X-ray diffraction. Compound 2 crystallizes in the triclinic system with space group P − 1, a = 8.5553(17) Å, b = 9.6229(19) Å, c = 9.924(2) Å, α = 106.16(3)°, β = 108.03(3)°, γ = 105.14(3)°, V = 690.1(2) Å3, Z = 2. The compound 3 crystallizes in the orthorhombic system with space group Pbca, a = 12.904(3) Å, b = 15.864(3) Å, c = 19.140(4) Å, α = 90°, β = 90°, γ = 90°, V = 3918.3(14) Å3, Z = 8. H-bonds and π–π stacking are the main non-bonding interactions in the molecular structure. Details of the synthesis, structures, and spectroscopic properties of the two compounds are discussed.
Graphical Abstract
The crystal structures of the compounds 1-phenyl-2-(1H-1,2,4-triazolo-yl)-3-phenyl-propen-1-one (2), and 2,4-diphenyl-3-(1,2,4-triazolo-yl)-1H,4H-1,5-benzothiazepine (3) were obtained by single crystal X-ray diffraction. Compound 2 crystallizes in the triclinic system with space group P − 1, a = 8.5553(17) Å, b = 9.6229(19) Å, c = 9.924(2) Å, α = 106.16(3)°, β = 108.03(3)°, γ = 105.14(3)°, V = 690.1(2) Å3, Z = 2. The compound 3 crystallizes in the orthorhombic system with space group Pbca, a = 12.904(3) Å, b = 15.864(3) Å, c = 19.140(4) Å, α = 90°, β = 90°, γ = 90°, V = 3918.3(14) Å3, Z = 8. H-bonds and π–π stacking are the main non-bonding interactions in the molecular structure. Details of the synthesis, structures, and spectroscopic properties of the two compounds are discussed.
Similar content being viewed by others
References
Catarzi D, Colotta V, Varano F, Filacchioni G, Galli A, Costagli C, Carlà V (2001) J Med Chem 44:3157–3165
Catarzi D, Colotta V, Varano F, Calabri FR, Filacchioni G, Galli A, Costagli C, Carlà V (2004) J Med Chem 47:262–272
Kumar RR, Perumal S (2007) Tetrahedron 63:7850–7857
Santo RD, Costi R (2005) IL FARMACO 60:385–392
Grandolini G, Perioli L, Ambrogi V (1999) Eur J Med Chem 34:701
Levai A (1999) Pharmazie 54:719
Darias V, Sanchez Mateo CC, Exposito Orta MA, Albertos LM, Diaz JA, Vega S (1999) Pharmazie 54:783
Naik VR, Naik HB (1999) Asian J Chem 11:661
Piselli FL, Boschi P, Navoni C (1995) Chem Abstr 121:9433. EP 594101
Tanoury GJ, Senanayake CH, Hett R, Kuhn AM, Kessler DW, Wald SA (1998) Tetrahedron Lett 39:6845
Sui Z, Guan G, Hlasta DJ, Macielag MJ, Foleno BD, Goldschmidt RM, Loeloff MJ, Webb GC, Barrett JF (1998) Bioorg Med Chem Lett 8:1929
Buchenauer H (1977) Proc Br Crop Protect Conf 2:699
Yang DB, Liu FM, Ding F, Shen SW, Zhou YL, Ye JW, Fei TH (2008) J Hangzhou Normal Univ (Nat Sci Edn) 7:4
Shi YN, Yang Y, Fang JX (1996) Chem J Chin Univ 17:1578
Sheldrick GM (1997) SHELXS-97. Program for crystal structure refinement. University of Gottingen, Germany
Spek AL (2008) PLATON. A multipurpose crystallographic tool. Utrecht University, Utrecht, TheNetherlands
Acknowledgements
The authors thank the National Natural Science Foundation of China (No: 20562011, 20662009) for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, SQ., Liu, FM. Synthesis and Crystal Structure of Compound 1-Phenyl-2-(1H-1,2,4-triazolo-yl)-3-phenyl-propen-1-one and 1-Diphenyl-3-(1,2,4-triazolo-yl)-1H,4H-1,5-benzothiazepine. J Chem Crystallogr 41, 485–490 (2011). https://doi.org/10.1007/s10870-010-9906-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10870-010-9906-4